Neurelis

Neurelis is a biotech company in San Diego, United States, founded in 2007. It has raised $228.0M across 5 rounds, most recently a $114.0M Series D in March 2021.

Neurelis®: Helping More People Define Their Neu Normal

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$228.0M
Last Round
$114.0M Series DMar 2021
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 4 investors for this company. The full record is or through the API.

About

Neurelis is a commercial-stage neuroscience company founded in 2007 in San Diego, focused on developing and commercializing therapeutics for epilepsy and central nervous system disorders. Its flagship product, approved by the FDA, leverages proprietary Intravail absorption technology and has achieved coverage of over 285 million insured US lives.

Summary

It lists 51–200 employees. It has raised $228.0M in total across 5 rounds, most recently a $114.0M Series D round in Mar 2021. Investors include HBM Healthcare Investments, Cormorant and OrbiMed.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series DSeries DMar 2021
$114.0M

Sign up to see all 6 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurelis on Indexed.vc
<a href="https://indexed.vc/companies/neurelis-inc"><img src="https://indexed.vc/api/badge/company/neurelis-inc" alt="Neurelis on Indexed.vc" width="260" height="76" /></a>